Aggregation and analysis of indication-symptom relationships for drugs approved in the USA.

Ananth PunyalaRachana LankapalliDiane HindmanRebecca Racz

Published in: European journal of clinical pharmacology (2020)

The drug-indication associations and disease-symptom associations collected in this study may be useful in identifying confounders in other datasets, such as safety reports. With further refinement and additional drugs, indications, and symptoms, this dataset may become a quality resource for disease symptoms.

Keyphrases

sleep quality
adverse drug
emergency department
patient reported
depressive symptoms
drug administration